Canaccord Genuity reiterates a 'Buy' on AcelRx Pharmaceuticals (ACRX); Hercules Loan Shores Up Cash for ARX-01 Pivotal Trial Costs

Go back to Canaccord Genuity reiterates a 'Buy' on AcelRx Pharmaceuticals (ACRX); Hercules Loan Shores Up Cash for ARX-01 Pivotal Trial Costs